SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000819050-22-000059
Filing Date
2022-05-12
Accepted
2022-05-12 16:12:19
Documents
54
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bbi-20220331.htm   iXBRL 10-Q 994140
2 EX-31.1 a2022033110qex311.htm EX-31.1 10110
3 EX-31.2 a2022033110qex312.htm EX-31.2 9839
4 EX-32.1 a2022033110qex321.htm EX-32.1 8908
10 bbi-20220331_g1.jpg GRAPHIC 1078945
  Complete submission text file 0000819050-22-000059.txt   6506510

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbi-20220331.xsd EX-101.SCH 33820
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bbi-20220331_cal.xml EX-101.CAL 31098
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bbi-20220331_def.xml EX-101.DEF 132711
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbi-20220331_lab.xml EX-101.LAB 369342
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbi-20220331_pre.xml EX-101.PRE 232153
48 EXTRACTED XBRL INSTANCE DOCUMENT bbi-20220331_htm.xml XML 444231
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21088 | Film No.: 22917931
SIC: 2836 Biological Products, (No Diagnostic Substances)